vs

Side-by-side financial comparison of Meridian Corp (MRBK) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $34.2M, roughly 1.7× Meridian Corp). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 5.1%). Meridian Corp produced more free cash flow last quarter ($22.6M vs $-167.0M).

Meridian Audio is a consumer audio and home theatre equipment manufacturer based in the United Kingdom. Bob Stuart and Allen Boothroyd founded the company in 1977 under the name Boothroyd-Stuart. In 1985 the company released a CD player under the brand name, Meridian. The company also created the lossless compression format Meridian Lossless Packing in 1998 and the lossy Master Quality Authenticated (MQA) format in 2014.

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

MRBK vs PHAT — Head-to-Head

Bigger by revenue
PHAT
PHAT
1.7× larger
PHAT
$57.6M
$34.2M
MRBK
Growing faster (revenue YoY)
PHAT
PHAT
+89.0% gap
PHAT
94.1%
5.1%
MRBK
More free cash flow
MRBK
MRBK
$189.6M more FCF
MRBK
$22.6M
$-167.0M
PHAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRBK
MRBK
PHAT
PHAT
Revenue
$34.2M
$57.6M
Net Profit
$7.2M
Gross Margin
86.7%
Operating Margin
27.2%
Net Margin
428.0%
Revenue YoY
5.1%
94.1%
Net Profit YoY
28.3%
71.6%
EPS (diluted)
$0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRBK
MRBK
PHAT
PHAT
Q4 25
$34.2M
$57.6M
Q3 25
$33.1M
$49.5M
Q2 25
$32.4M
$39.5M
Q1 25
$27.1M
$28.5M
Q4 24
$32.6M
$29.7M
Q3 24
$29.1M
$16.4M
Q2 24
$26.1M
$7.3M
Q1 24
$24.6M
Net Profit
MRBK
MRBK
PHAT
PHAT
Q4 25
$7.2M
Q3 25
$6.7M
$-30.0M
Q2 25
$5.6M
$-75.8M
Q1 25
$2.4M
$-94.3M
Q4 24
$5.6M
Q3 24
$4.7M
$-85.6M
Q2 24
$3.3M
$-91.4M
Q1 24
$2.7M
Gross Margin
MRBK
MRBK
PHAT
PHAT
Q4 25
86.7%
Q3 25
87.5%
Q2 25
87.2%
Q1 25
86.9%
Q4 24
87.1%
Q3 24
85.6%
Q2 24
81.2%
Q1 24
Operating Margin
MRBK
MRBK
PHAT
PHAT
Q4 25
27.2%
Q3 25
26.2%
-30.8%
Q2 25
22.5%
-151.7%
Q1 25
11.6%
-276.5%
Q4 24
23.3%
Q3 24
21.5%
-433.0%
Q2 24
16.8%
-1055.4%
Q1 24
14.4%
Net Margin
MRBK
MRBK
PHAT
PHAT
Q4 25
428.0%
Q3 25
20.1%
-60.5%
Q2 25
17.2%
-191.9%
Q1 25
8.9%
-330.7%
Q4 24
366.8%
Q3 24
16.3%
-523.3%
Q2 24
12.7%
-1248.6%
Q1 24
10.9%
EPS (diluted)
MRBK
MRBK
PHAT
PHAT
Q4 25
$0.61
Q3 25
$0.58
$-0.41
Q2 25
$0.49
$-1.05
Q1 25
$0.21
$-1.31
Q4 24
$0.49
Q3 24
$0.42
$-1.32
Q2 24
$0.30
$-1.56
Q1 24
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRBK
MRBK
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$130.0M
Total DebtLower is stronger
$209.1M
Stockholders' EquityBook value
$199.7M
$-438.2M
Total Assets
$2.6B
$259.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRBK
MRBK
PHAT
PHAT
Q4 25
$130.0M
Q3 25
$135.2M
Q2 25
$149.6M
Q1 25
$212.3M
Q4 24
$297.3M
Q3 24
$334.7M
Q2 24
$276.2M
Q1 24
Total Debt
MRBK
MRBK
PHAT
PHAT
Q4 25
$209.1M
Q3 25
$207.1M
Q2 25
$205.1M
Q1 25
$203.2M
Q4 24
$201.4M
Q3 24
$175.7M
Q2 24
$174.4M
Q1 24
Stockholders' Equity
MRBK
MRBK
PHAT
PHAT
Q4 25
$199.7M
$-438.2M
Q3 25
$188.0M
$-422.5M
Q2 25
$178.0M
$-405.8M
Q1 25
$173.6M
$-338.4M
Q4 24
$171.5M
$-253.6M
Q3 24
$167.4M
$-187.1M
Q2 24
$162.4M
$-233.8M
Q1 24
$159.9M
Total Assets
MRBK
MRBK
PHAT
PHAT
Q4 25
$2.6B
$259.1M
Q3 25
$2.5B
$240.3M
Q2 25
$2.5B
$250.2M
Q1 25
$2.5B
$294.2M
Q4 24
$2.4B
$378.3M
Q3 24
$2.4B
$387.0M
Q2 24
$2.4B
$319.4M
Q1 24
$2.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRBK
MRBK
PHAT
PHAT
Operating Cash FlowLast quarter
$24.3M
$-166.8M
Free Cash FlowOCF − Capex
$22.6M
$-167.0M
FCF MarginFCF / Revenue
65.9%
-290.0%
Capex IntensityCapex / Revenue
5.1%
0.4%
Cash ConversionOCF / Net Profit
3.38×
TTM Free Cash FlowTrailing 4 quarters
$51.7M
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRBK
MRBK
PHAT
PHAT
Q4 25
$24.3M
$-166.8M
Q3 25
$24.4M
$-14.1M
Q2 25
$-12.0M
$-62.7M
Q1 25
$18.1M
$-84.9M
Q4 24
$9.6M
$-266.8M
Q3 24
$31.2M
$-63.6M
Q2 24
$-19.2M
$-70.7M
Q1 24
$-1.7M
Free Cash Flow
MRBK
MRBK
PHAT
PHAT
Q4 25
$22.6M
$-167.0M
Q3 25
$24.0M
$-14.1M
Q2 25
$-12.7M
$-62.8M
Q1 25
$17.9M
$-84.9M
Q4 24
$9.0M
$-266.9M
Q3 24
$29.5M
$-63.6M
Q2 24
$-19.3M
$-70.8M
Q1 24
$-3.6M
FCF Margin
MRBK
MRBK
PHAT
PHAT
Q4 25
65.9%
-290.0%
Q3 25
72.4%
-28.6%
Q2 25
-39.1%
-159.0%
Q1 25
65.9%
-297.9%
Q4 24
27.7%
-899.8%
Q3 24
101.4%
-389.0%
Q2 24
-73.8%
-966.2%
Q1 24
-14.7%
Capex Intensity
MRBK
MRBK
PHAT
PHAT
Q4 25
5.1%
0.4%
Q3 25
1.4%
0.1%
Q2 25
1.9%
0.2%
Q1 25
1.0%
0.1%
Q4 24
1.7%
0.5%
Q3 24
6.0%
0.3%
Q2 24
0.2%
0.6%
Q1 24
7.8%
Cash Conversion
MRBK
MRBK
PHAT
PHAT
Q4 25
3.38×
Q3 25
3.66×
Q2 25
-2.15×
Q1 25
7.55×
Q4 24
1.71×
Q3 24
6.58×
Q2 24
-5.78×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons